Fundraising FoxAtrility Medical
Madison, US · Founded 2017 · 1 known investors
Find your way into Atrility Medical
Sign up to see every warm intro you have to Atrility Medical
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Atrility Medical team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Atrility develops cardiac medical devices, including the AtriAmp for post-operative arrhythmia monitoring, aimed at improving care for cardiac patients. The company combines healthcare, business, and engineering expertise to bring medical technology to market.
Founders & leadership
Atrility Medical was founded in 2017 by Matt Knoespel, Phil Terrien, Nick Von Bergen, M.D., and Pete Lukszys.
MK
Matt KnoespelVP of Commercialization, Founder
NV
Nick Von Bergen, M.D.CMO, Board Member, Founder
PL
Pete LukszysSenior Advisor, Founder
SM
Sean McCormickChief Executive OfficerSean McCormick is a physician with over 20 years of clinical and industry experience, now CEO of Atrility, which develops cardiac medical devices including the AtriAmp for post-operative arrhythmia monitoring. He has expertise in creating data-driven healthcare strategies and working across clinical, business, and engineering domains.
MB
Mike BressCFO
NV
Nicholas Von BergenNamed on SEC filing
Board
CE
Christopher EckstromBoard directorPartner at Rock River Capital Partners
MP
Michael PartschBoard director
Investors · 1
Reported raises · per SEC filings
Form D private placements$5M disclosed across 4 rounds · 2018–2025
▶$1MraisedFeb 2026 · 3 investors · Other Health CareRule 506(b)
▶$1MraisedFeb 2026 · 3 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Sean McCormickExecutive Officer, Director
- Christopher EckstromDirector
- Nicholas Von BergenDirector
- Michael PartschDirector
- Offering amount
- $2M
- Amount sold
- $1M
- First sale
- Nov 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$3.4MraisedJun 2022 · 15 investors · Other Health CareRule 506(b)
▶$3.4MraisedJun 2022 · 15 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Chris R. EckstromDirector
- Michael J. PartschDirector
- Nicholas Von BergenDirector, Promoter
- Peter LukszysExecutive Officer, Promoter
- David B. KaysenExecutive Officer, Director, Promoter
- Offering amount
- $3.8M
- Amount sold
- $3.4M
- Minimum investment
- $20K
- First sale
- Jun 2022
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
▶$300KraisedOct 2020 · 1 investors · Other Health CareRule 506(b)
▶$300KraisedOct 2020 · 1 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Nicholas Von BergenExecutive Officer, Director
- Peter LukszysExecutive Officer, Director
- Offering amount
- $700K
- Amount sold
- $300K
- Minimum investment
- $25K
- Proceeds to insiders
- $20K
- First sale
- Sep 2020
- Incorporated
- Limited Liability Company, Wisconsin, 2017
- Federal exemptions
- 06b
▶$310KraisedApr 2018 · 7 investors · Other Health CareRule 506(b)
▶$310KraisedApr 2018 · 7 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Peter LukszysExecutive Officer, Director
- Nicholas Von BergenExecutive Officer, Director
- Offering amount
- $500K
- Amount sold
- $310K
- Minimum investment
- $15K
- First sale
- Feb 2018
- Incorporated
- Limited Liability Company, Wisconsin, 2017
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 2
iRhythmiRhythm provides wearable cardiac monitoring devices and AI-powered analysis services for clinicians to diagnose heart arrhythmias. The platform combines engineered ECG monitors, machine learning algorithms, and expert clinical review to deliver actionable diagnostic reports.
Boston ScientificBoston Scientific supports external researcher-initiated studies through its Investigator Sponsored Research program, which funds independent investigations addressing disease understanding and treatment gaps of interest to the medical community.
Companies working in the same space as Atrility Medical.
Frequently asked questions
- What does Atrility Medical do?
- Atrility develops cardiac medical devices, including the AtriAmp for post-operative arrhythmia monitoring, aimed at improving care for cardiac patients. The company combines healthcare, business, and engineering expertise to bring medical technology to market.
- Who founded Atrility Medical?
- Atrility Medical was founded by Matt Knoespel, Phil Terrien, Nick Von Bergen, M.D., Pete Lukszys in 2017.
- Who are Atrility Medical's investors?
- Atrility Medical's investors include Rock River Capital Partners.
- How much funding has Atrility Medical raised?
- Atrility Medical has disclosed $5M raised across 4 rounds.
- Where is Atrility Medical headquartered?
- Atrility Medical is headquartered in Madison, US.